Wednesday - December 10, 2025

Actinium Pharmaceuticals (NYSEAMERICAN: ATNM) Begins European Phase 1 Trial of Nectin-4 Targeted Alpha Therapy for Multiple Solid Tumors

Innovation in oncology continues to accelerate, with global cancer R&D spending now exceeding hundreds of billions annually and more than a thousand new trials launched each year. Among the fastest-growing segments is radiopharmaceuticals, attracting significant investment as major pharmaceutical companies … Continue reading

ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active

ENDRA Life Sciences (NASDAQ: NDRA) is redefining how emerging health-tech companies accelerate breakthrough innovation while maintaining disciplined capital efficiency. The developer of TAEUS® (Thermo-Acoustic Enhanced UltraSound) has implemented a modern treasury strategy managed by Arca Investment Management, converting idle cash … Continue reading

SurgePays (NASDAQ: SURG) Expands Growth Strategy – New Lead-Driver to Boost Fintech Revenue – More Stocks Inside

SurgePays, Inc. (NASDAQ: SURG), a rapidly expanding technology and telecommunications company serving the prepaid and underserved consumer markets, released an update highlighting its multi-vertical growth strategy designed to scale revenue across wireless, fintech, and retail partner ecosystems. The company confirmed … Continue reading